Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis. [electronic resource]
Producer: 20200908Description: 2081-2088 p. digitalISSN:- 1538-7836
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Anticoagulants -- administration & dosage
- Arthroplasty, Replacement, Knee -- adverse effects
- Blood Coagulation -- drug effects
- Double-Blind Method
- Factor Xa Inhibitors -- administration & dosage
- Female
- Hemorrhage -- chemically induced
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Thrombin -- antagonists & inhibitors
- Thrombin Time
- Time Factors
- Treatment Outcome
- Venous Thromboembolism -- blood
- Venous Thrombosis -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.